TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04176315

Usability and Effectiveness of ReHub in Patients After Total Hip Arthroplasty

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“COVID-19”

The sponsor’s own words in the registry.

Life of this trial

201920202021Registered2019-11-22Started2019-12-04Stopped2020-12-19

Vital statistics

Status
Terminated
Phase
Na
Sponsor
Bio-Sensing Solutions S.L. (DyCare)
Sponsor type
Industry
Conditions
Hip Osteoarthritis
Interventions
Conventional Home-based Rehabilitation Plan; ReHub Home-based Rehabilitation Plan
Participants
38
Sites
1
Countries
Italy

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.